Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sporotrichosis.

B S Belknap1

  • 1Division of Dermatology, University of North Dakota School of Medicine, Grand Forks, North Dakota.

Dermatologic Clinics
|April 1, 1989
PubMed
Summary

Sporotrichosis, a fungal infection, has various forms. Itraconazole shows promise for treating cutaneous sporotrichosis, potentially shortening therapy and reducing relapses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of halcinonide cream, 0.1 percent, in the treatment of moderate and severe dermatoses.

Cutis·1981
Same author

Topical erythromycin solution in acne. Results of a multiclinic trial.

Journal of the American Academy of Dermatology·1980
Same author

Treatment of acne with 5% benzoyl peroxide gel or 0.05% retinoic acid cream.

Cutis·1979
See all related articles

Area of Science:

  • Mycology
  • Infectious Diseases
  • Dermatology

Background:

  • Sporotrichosis is a chronic fungal infection primarily affecting skin and lymphatics.
  • It presents in five distinct clinical forms: lymphocutaneous, fixed cutaneous, disseminated cutaneous, pulmonary, and systemic.
  • Diagnosis relies on fungal culture or direct immunofluorescence.

Observation:

  • Oral potassium iodide and local heat are established treatments for cutaneous sporotrichosis.
  • Itraconazole, a triazole antifungal, demonstrates efficacy against Sporothrix schenckii.
  • Systemic sporotrichosis is increasing, particularly in immunocompromised individuals, posing diagnostic and management challenges.

Findings:

  • Itraconazole may reduce treatment duration and relapse rates for cutaneous sporotrichosis.
  • Serologic tests, like slide latex agglutination, aid in diagnosing systemic sporotrichosis and monitoring treatment.
  • Intravenous amphotericin B remains the standard for systemic cases, though less toxic alternatives are sought.

Implications:

  • Newer agents like itraconazole offer potential improvements in managing sporotrichosis.
  • Effective diagnosis and treatment of systemic sporotrichosis require careful consideration of patient status and disease extent.
  • Combination therapy and surgical options may be necessary for complex or extracutaneous presentations.

Related Experiment Videos